· National medical insurance products
· Children's antibiotics are preferred in small doses and good taste

Specification: 0.1g/0.25g according to C15H14CLN3O4S
Drug category: Western medicine
National Health Insurance: Category B

Indications: This product is mainly suitable for respiratory system, urinary system, ENT and skin and soft tissue infections caused by sensitive bacteria.

Pharmacological effects: This product is a broad-spectrum semi-synthetic cephalosporin antibiotic. The activity against penicillinase-producing Staphylococcus aureus, group A hemolytic streptococcus, viridans streptococcus and staphylococcus epidermidis is the same as that of cefadroxil, and its antibacterial effect on non-enzyme-producing Staphylococcus aureus and pneumococcus is higher than that of cefadrox. Ampicillin is 2 to 4 times stronger. The activity against gram-negative bacilli including Escherichia coli and Klebsiella pneumoniae is stronger than that of cephalexin, similar to cefadroxil, and the activity against Proteus mirabilis, Salmonella and Shigella is stronger than that of cefadroxil . 2.9~8MG/L of this product can inhibit all Haemophilus influenzae, including ampicillin-resistant strains. Moraxella catarrhalis and Neisseria gonorrhoeae are sensitive to this product. Indole-positive Proteus, Serratia, Acinetobacter and Pseudomonas aeruginosa were all resistant to this product.
The mechanism of action of this product is to inhibit the synthesis of bacterial cell walls.